08037.HK
China Biotech Services Holdings Limited
HKSE · Healthcare · Medical - Diagnostics & Research · HK
HKD 0.47
−4.08%Margins
Gross margin
12.5%
EBITDA margin
-60.4%
EBIT margin
-98.5%
Net margin
-77.8%
FCF margin
-135.2%
-52.3%
Return on equity
-13.9%
Return on assets
-21.1%
Return on invested capital
—
Asset turnover
-HKD 54.5M
Cash from operations
HKD 0.06
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026